metoclopramide hydrochloride · Qol Medcl · NDA 209388
Gimoti
Earliest generic entry, as listed
17 Nov 2038
Blocked by patent: US 12377064. Only method-of-use patents remain, so a generic may carve out the protected indication and enter earlier.
Listed patents · 7 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12377064 | use U-2843 | 17 Nov 2038 |
| US 8334281 | product, use U-2843 | 16 May 2030 |
| US 11020361 | use U-2843 | 22 Dec 2029 |
| US 11628150 | product, use U-2843 | 22 Dec 2029 |
| US 11813231 | product, use U-2843 | 22 Dec 2029 |
| US 12194008 | use U-2843 | 22 Dec 2029 |
| US 12194009 | use U-2843 | 22 Dec 2029 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209388 · 001 · RLD | spray, metered, nasal | EQ 15MG BASE/SPRAY | 17 Nov 2038 |